UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities.
Doctors promote prevention during Oral and Head and Neck Cancer Awareness Month
Hematology researchers have further refined how a treatment currently used urgently to control bleeding in hemophilia patients holds promise for prevention as well. A study in animals may lead to a new therapy for patients who now develop antibodies to the standard maintenance treatment.
Through partnerships with Sanofi Argentina, Sanofi Chile, Sanofi Colombia, Sanofi Pacific and Caribbean, Sanofi Peru and Sanofi Uruguay, the Endocrine Society hosted its first Latin American (LATAM) Leadership Academy. Sixty-two clinicians from over 15 countries across South America, Central America and the Caribbean took part in a one-day leadership training program and attended ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
Georgetown University faculty offer expertise for journalists seeking interviews in a variety of subjects related to Ebola. Topics include WHO, Public Health Emergency of International Concern (PHEIC), International Health Regulations, infectious disease control and treatment, vaccine development, clinical trials, and global health security and law.
Dr. Leena Pattarkine and Dr. Shailaja Agrawal are partnering with students to design and fabricate a tool that will aid in the growth of cell cultures via a 3D platform. Launched this spring, the “Biopolymer Sponge Microfluidics for Continuous 3D Cell Culture and Drug Screening Project” aims to transform the field of drug screening and make it much more cost effective.
Southern Research and Japan’s Ina Research announced today they have formed a partnership that calls for Ina to help connect Southern Research with potential new customers for drug development services in the country with the world’s third largest pharmaceutical industry.
Below are summaries of recent Fred Hutch research, with links for additional background and media contacts.
ASCO, ASH, and NCCN receive letter clarifying CDC Guideline for Prescribing Opioids for Chronic Pain not meant to limit access to appropriate pain management for individuals with cancer, sickle cell disease
A glimpse into the future of global public health: a credit-card sized piece of paper is dunked into a liquid sample at a health clinic in a developing nation, quickly telling a doctor or nurse whether a malnourished child with diarrhea is infected with a virus, a bacteria, or a parasitic protozoan.
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American College of Radiology (ACR) announce a new collaborative clinical data registry to support high-quality practice and patient care. The registry will allow collection and analysis of data on nuclear medicine procedures, supporting continuous improvement of patient care.
In January scientists at Vanderbilt University Medical Center (VUMC) and colleagues in Boston, Seattle and St. Louis were given an audacious goal to develop — in 90 days — a protective antibody-based treatment that potentially will stop the spread of the Zika virus.
Researchers are investigating whether monitoring brain tissue oxygen levels in patients with severe traumatic brain injury (TBI) results in higher rates of survival and functionality. The trial at The University of Texas Health Science Center at Houston (UTHealth) is part of a nationwide study that is funded by the National Institutes of Health.
The U.S. Food and Drug Administration’s approval today of atezolizumab (Tecentriq®, Genentech) in combination with chemotherapy (carboplatin and etoposide) for the initial treatment of extensive-stage small cell lung cancer (SCLC) marks the end of numerous failed attempts to improve survival for those with the deadly disease.
The 33 million people with atrial fibrillation worldwide not only suffer from bothersome symptoms, but also face a fivefold increased risk of stroke and a twofold increased risk of death. Research teams led by Mayo Clinic published three connected studies on Friday, March 15, clarifying the benefits of catheter ablation versus rate- or rhythm-control medications to treat atrial fibrillation.
New preclinical data from University of California San Diego School of Medicine and Moores Cancer Center offers proof-of-principle for a combination immunotherapy that suppresses tumor growth in the liver. Current therapies for liver cancer are largely ineffective, resulting in poor outcomes.
Findings in Journal of the National Cancer Institute shows patients don’t have enough opportunities for participation
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right